NCT07143695

Brief Summary

Increased days of MV are not without hazards, including barotraumas and ventilator-associated pneumonia. Similarly, premature separation of MV is associated with increased mortality secondary to adverse cardiorespiratory events. Therefore, the time of weaning should be wisely evaluated. There is growing evidence concerning respiratory muscles dysfunction that contributes to difficulty or prolonged liberation from MV.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
4mo left

Started Sep 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress68%
Sep 2025Aug 2026

First Submitted

Initial submission to the registry

August 20, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 27, 2025

Completed
5 days until next milestone

Study Start

First participant enrolled

September 1, 2025

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2026

Last Updated

September 8, 2025

Status Verified

September 1, 2025

Enrollment Period

11 months

First QC Date

August 20, 2025

Last Update Submit

September 1, 2025

Conditions

Keywords

Weaningre-intubationmechanical ventilation

Outcome Measures

Primary Outcomes (1)

  • Incidence of reintubation

    need for reintubation

    Within 72 hours after extubation

Secondary Outcomes (1)

  • Incidence of weaning failure

    within 72 hours post-extubation

Study Arms (2)

Control group

SHAM COMPARATOR

patients in control will be weaning using standard criteria

Device: Sham parasternal intercostal thickening

Ultrasound

ACTIVE COMPARATOR

patient in this group will be weaned using standard criteria plus mean parasternal thickening fraction less than 6.5 %

Device: Parasternal intercostal thickening fraction

Interventions

Parasternal intercostal thickening fraction less than 6.5%

Ultrasound

Ultrasound assessment only for purpose of blinding

Control group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • critically ill patient mechanically ventilated for 24 hours or more first spontaneous breathing trial

You may not qualify if:

  • patient refusal difficult ultrasound views tracheostomized patient neuromuscular disorders

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cairo University

Cairo, Giza Governorate, 6890, Egypt

RECRUITING

Related Publications (3)

  • Helmy MA, Hasanin A, Milad LM, Mostafa M, Fathy S. Parasternal intercostal muscle thickening as a predictor of non-invasive ventilation failure in patients with COVID-19. Anaesth Crit Care Pain Med. 2022 Jun;41(3):101063. doi: 10.1016/j.accpm.2022.101063. Epub 2022 Apr 26. No abstract available.

    PMID: 35487407BACKGROUND
  • Helmy MA, Milad LM, Hasanin AM, Mostafa M, Mannaa AH, Youssef MM, Abdelaziz M, Alkonaiesy R, Elshal MM, Hosny O. Parasternal intercostal thickening at hospital admission: a promising indicator for mechanical ventilation risk in subjects with severe COVID-19. J Clin Monit Comput. 2023 Oct;37(5):1287-1293. doi: 10.1007/s10877-023-00989-4. Epub 2023 Mar 24.

    PMID: 36961635BACKGROUND
  • Helmy MA, Hasanin A, Milad LM, Mostafa M, Hamimy WI, Muhareb RS, Raafat H. Ability of parasternal intercostal muscle thickening fraction to predict reintubation in surgical patients with sepsis. BMC Anesthesiol. 2024 Aug 22;24(1):294. doi: 10.1186/s12871-024-02666-8.

    PMID: 39174907BACKGROUND

MeSH Terms

Conditions

Critical Illness

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of anesthesia and critical care

Study Record Dates

First Submitted

August 20, 2025

First Posted

August 27, 2025

Study Start

September 1, 2025

Primary Completion (Estimated)

August 1, 2026

Study Completion (Estimated)

August 31, 2026

Last Updated

September 8, 2025

Record last verified: 2025-09

Locations